|
⚲
|
| Keyboard |
| Stephen Tullman | |
|---|---|
| Firm | |
| Address | 11 Kyle Drive Chester Springs, PA 19426 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Nexeos Diagnostics Inc | 021-573648 | Executive Officer | 3.0 M of 3.0 M |
||
| Nexeos Diagnostics Inc | 021-515331 | Executive Officer | 4.9 M of 4.9 M |
||
| Nexeos Diagnostics Inc | 021-473497 | Executive Officer | 5.1 M of 5.1 M |
||
| Nexeos Diagnostics Inc | 021-416582 | Director | 9.7 M of 9.7 M |
||
| Velicept Therapeutics Inc | 021-353767 | Director | 6.0 M of 9.2 M |
||
| Nexeos Diagnostics Inc | 021-345327 | Executive Officer | 3.0 M of 5.5 M |
||
| Ralexar Therapeutics Inc | 021-329633 | Executive Officer | 4.3 M of 6.0 M |
||
| Zoomi Inc | 021-327971 | Director | 0.9 M of 1.2 M |
||
| Velicept Therapeutics Inc | 021-317168 | Director | 15.5 M of 15.6 M |
||
| Myota Inc | 021-312519 | Director | 2.1 M of 2.1 M |
||
| Aclaris Therapeutics Inc | 021-292766 | Director | 10.0 M of 12.5 M |
||
| Onspira Therapeutics Inc | 021-289166 | Executive Officer | 1.9 M of 1.9 M |
||
| Ralexar Therapeutics Inc | 021-288286 | Executive Officer | 4.1 M of 6.9 M |
||
| Zoomi Inc | 021-277989 | Director | 6.8 M of 7.5 M |
||
| Zoomi Inc | 021-265132 | Director | 2.5 M of 2.5 M |
||
| Velicept Therapeutics Inc | 021-252193 | Director | 18.4 M of 26.3 M |
||
| Aclaris Therapeutics Inc | 021-247471 | Director | 40.0 M of 40.0 M |
||
| Zoomi Inc | 021-245760 | Director | 1.5 M of 1.5 M |
||
| Zoomi Inc | 021-232839 | Director | 4.4 M of 4.7 M |
||
| Aclaris Therapeutics Inc | 021-226021 | Director | 10.6 M of 21.3 M |
||
| Alexar Therapeutics Inc | 021-209726 | Director | 10.6 M of 21.5 M |
||
| Aclaris Therapeutics Inc | 021-183855 | Director | 20.9 M of 20.9 M |
||
| Ceptaris Therapeutics Inc | 021-178599 | Executive Officer | 8.3 M of 10.0 M |
||
| Yaupon Therapeutics Inc | 021-164580 | Executive Officer | 8.2 M of 8.2 M |
||
| Vicept Therapeutics Inc | 021-133791 | Director | 15.8 M of 15.8 M |
||